|
|
Volumn 50, Issue 6, 2010, Pages 1101-1102
|
|
Triptans, SSRIs/SNRIs and serotonin syndrome
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FLUOXETINE;
SEROTONIN NORADRENALIN REUPTAKE INHIBITOR;
SEROTONIN UPTAKE INHIBITOR;
SUMATRIPTAN;
SUMATRIPTAN SUCCINATE;
SUMAVEL;
TRIPTAN DERIVATIVE;
UNCLASSIFIED DRUG;
VENLAFAXINE;
TRYPTAMINE DERIVATIVE;
CLINICAL ASSESSMENT;
CLINICAL FEATURE;
COMORBIDITY;
DEPRESSION;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE PERSONNEL;
HUMAN;
MIGRAINE;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
SEROTONIN SYNDROME;
CHEMICALLY INDUCED;
DEPRESSIVE DISORDER;
MIGRAINE DISORDERS;
PATIENT EDUCATION;
DEPRESSIVE DISORDER;
HUMANS;
MIGRAINE DISORDERS;
SEROTONIN SYNDROME;
SEROTONIN UPTAKE INHIBITORS;
TRYPTAMINES;
|
|
EID: 77953195193
PISSN: 00178748
EISSN: 15264610
Source Type: Journal
DOI: 10.1111/j.1526-4610.2010.01692.x Document Type: Editorial |
|
Times cited : (2)
|
|
References (0)
|
